CARMEL, Ind., Nov. 26, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today its participation in the Noble Financial Capital Markets 20th Annual Equity Conference, known as NobleCon20, taking place December 3-4 in Boca Raton, Florida.Syra Health CEO, Dr. Deepika Vuppalanchi, will present at the prestigious event, which highlights emerging growth companies. Dr. Vuppalan ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $0.001 par value SYRA The Nasdaq Stock Market LLC FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____ ...

Exhibit 99.1 Syra Health Delivers Third Quarter 2024 Financial Results Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year Quarter Gross Margins Increased Following Shift in Operational Strategy Net Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024 Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Ef iciency Measures Conference call will be held today, Tuesday, October 29 at 9 ...

Achieved Net Revenue of $2.3 million, ~42% Growth Over the Prior Year QuarterGross Margins Increased Following Shift in Operational StrategyNet Loss Narrowed to $417,535 ($0.06 per share), a Significant Improvement from the $1.39 million ($0.21 per share) Net Loss in Q2 of 2024Aiming to Attain Profitability in 2025 through Targeted Revenue Growth and Cost-Efficiency MeasuresConference call will be held today, Tuesday, October 29th at 9:00 AM ETCARMEL, Ind., Oct. 29, 2024 /PRNewswire/ -- Syra Health Corp. (N ...

Conference call will be held on Tuesday, October 29 at 9:00 AM ETCARMEL, Ind., Oct. 22, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, t ...

CARMEL, Ind., Oct. 9, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, announced today more details about the award of three new healthcare workforce contracts: one in Florida, one in Kansas, and one in Delaware. In Florida, Syra Health has been awarded a contract to supply psychologists and school counselors to the St. John's County School District in St. Augustine. This effort u ...

CARMEL, Ind., Oct. 1, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA) ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, is celebrating its first anniversary as a publicly traded company and highlighting its many successes. This milestone not only marks the Company's growth but also reflects its unwavering commitment to transforming healthcare service. As the Company highlights significant achievements over the past year, it rema ...

CARMEL, Ind., Sept. 13, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, today announced the closing of its previously announced public offering of an aggregate of 3,203,125 shares of its Class A common stock, Series A warrants to purchase up to 3,203,125 shares of Class A common stock and Series B warrants to purchase up to 3,203,125 shares of Class A common stock (all the warra ...

CARMEL, Ind., Sept. 11, 2024 /PRNewswire/ -- Syra Health Corp. (NASDAQ: SYRA), ("Syra Health" or the "Company"), a healthcare technology company powering better health by providing meaningful solutions, today announced the pricing of a public offering of an aggregate of 3,203,125 shares of its Class A common stock, Series A warrants to purchase up to 3,203,125 shares of Class A common stock and Series B warrants to purchase up to 3,203,125 shares of Class A common stock (all the warrants, collectively, the ...

财务表现 - 2Q24营收为2.0百万美元，同比增长101%[3] - 毛利率为17.8%，同比增加468个基点[7] - 2024年净亏损为2,837,306美元[34] - 2023年净亏损为1,588,692美元[34] - 2024年经营活动产生的净现金流出为2,304,012美元[34] - 2023年经营活动产生的净现金流出为632,763美元[34] - 2024年投资活动产生的净现金流出为11,111美元[35] - 2023年投资活动产生的净现金流出为15,251美元[35] - 2024年筹资活动产生的净现金流入为629,400美元[36] - 2023年筹资活动产生的净现金流入为681,119美元[36] - 2024年末现金余额为1,594,352美元[37] - 2023年末现金余额为36,449美元[37] 业务发展 - 高毛利业务单元(包括人群健康)占总收入的28%，同比增长347%[3] - 人群健康业务同比增长276%[3] - 获得43亿美元的10年期联邦政府医疗人员外包合同[4] - 获得5.8百万美元的4年期印第安纳州健康教育培训合同[4] - 已在全国23个州开展业务[4] - 推出AI驱动的心理健康应用程序Syrenity，已为两家雇主成功实施[5] 财务状况 - 现金余额为1.6百万美元，无长期债务[3]